CG Oncology, Inc. (CGON)
66.21
-0.53
(-0.79%)
USD |
NASDAQ |
May 01, 16:00
66.21
0.00 (0.00%)
After-Hours: 17:40
CG Oncology EPS Diluted (Quarterly) : -0.5157 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Puma Biotechnology, Inc. | 0.2608 |
| Syndax Pharmaceuticals, Inc. | -0.7786 |
| UroGen Pharma Ltd. | -0.5453 |
| Cogent Biosciences, Inc. | -0.6934 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -41.31M |
| Revenue (Quarterly) | 2.322M |
| Total Expenses (Quarterly) | 43.63M |
| Enterprise Value | 4.779B |
| Gross Profit Margin (Quarterly) | -34.32% |
| Profit Margin (Quarterly) | -1.78K% |
| Earnings Yield | -3.14% |
| Normalized Earnings Yield | -3.145 |